Dendreon's Acquisition

Dendreon was acquired by Sanpower on January 10, 2017.

Dendreon is a biopharmaceutical company targeting cancer through the discovery, development, commercialization, and manufacturing of novel therapeutics. Its product Provenge is an autologous cellular …

Articles about Dendreon's Acquisition: